Skip to main content
. 2021 Aug;9(15):1264. doi: 10.21037/atm-21-525

Table 2. Characteristics of ddPCR outcomes of cfDNA per point in time.

T Moment of sample Analysis DNA concentration (ng/μL) Total DNA (ng) Allele name Wildtype concentration (copy/μL) Variant concentration (copy/μL) Variant percentage Remark
t=0 (baseline) Baseline cfDNA ddPCR 2.14 25.70 c.524G>A; p.R175H 198.5 0 0 Negative
t=2 (baseline + 14 w) CRE-I ddPCR 2.07 39.12 c.524G>A; p.R175H 499.3 0 0 Negative
t=3 (baseline + 21 w) CRE-II ddPCR 2.58 38.70 c.524G>A; p.R175H 425.8 0 0 Negative
t=8 (baseline + 27 m) FU I ddPCR 1.76 3.52 c.524G>A; p.R175H 51.0 0 0 Negative
t=9 (baseline + 30 m) FU II ddPCR 2.76 16.56 c.524G>A; p.R175H 217.0 0 0 Negative
WBCs-FU II ddPCR 3.82 38.20 c.524G>A; p.R175H 508.0 0 0 Negative
t=10 (baseline + 33 m) FU III ddPCR 1.02 19.28 c.524G>A; p.R175H 234.4 0.74 0.31 Positive
WBCs-FU III ddPCR 120 30.00 c.524G>A; p.R175H 282.0 0 0 Negative

TP53 p.R175H (chr17:007578406; c.524G>A). cfDNA, cell free deoxynucleic acid; CRE, clinical response evaluation; WBCs, white blood cells; FU, follow-up.